Yahoo Web Search

Search results

    • Q1 2024 Intellia Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 13 hours ago

      With this as a backdrop, we expect to end this year with five enrolling clinical studies, three of which are in Phase 3. This includes a newly planned Phase ...

    • Basic Materials Roundup: Market Talk

      Basic Materials Roundup: Market Talk

      The Wall Street Journal· 5 hours ago

      0723 GMT – Sibanye-Stillwater comfortably beat RBC Capital Markets’ estimates to adjusted Ebitda thanks to a strong performance from its U.S....